LASIK CLINIC NEW BUSINESS MODEL TO MEET THE SURGICAL COST CHALLENGES: A CONTRIBUTION TO DECREASE INDONESIA’S REFRACTIVE DISORDERS RATE AND TO MEET INDONESIA’S HEALTHY VISION OF 2020

Refractive surgery has been the second most common surgical procedure after cataract surgery in the eye health field in Indonesia. The projection of refractive disorder patients in Indonesia is about 4,6% of the population, according to the Indonesia’s Ministry of Health data in 2011. Uncorrected refractive disorders can lead to blind. LASIK stands for LaserAssisted in situ Keratomileusis. It is a type of laser surgery to treat myopia, astigmatism and hyperopia. Myopia is a very common refractive error that people in general usually have. The prevalence rates of myopia are the highest in Asian countries, Indonesia is not excluded. Lasik procedure helps to correct the shape of the cornea, enabling light to be focused on the retina. The main reasons for people with eye refractive disorder do not seek Lasik surgery treatment are the expensive cost, fear of surgery and other unnecessary feelings. In addition to that, external factors such as the limitation of medical personnel and eye clinic facilities that can perform Lasik surgery also contribute to the still-low number of the patients undergo the procedure. By considering the analysis of business plan components to build Lasik eye health services that offers an effective treatment with a flexible payment scheme, this business model provides a promising return of investment (RoI). Significant gap between the number of people with refractive disorders and available eye care services with Lasik surgery equipped with experienced human resources and the latest technology opens the market for health care industry in Indonesia. The biggest challenge lies on medical cost. This new business model in eye clinic provides profitable gain both for investor and for obtaining Indonesia’s Vision 2020. This article describes experience to develop and implement new business model in Lasik clinic in Jakarta to answer the medical cost challenges facing by the patients. The main goal is to encourage the nationwide replication to meet Indonesia’s Vision 2020.